Maynard Um
-
-
-
-
-
-
-
ProKidney secures FDA alignment on accelerated approval pathway for rilparencel
-
-
-
-
-
-
-
BofA Securities Reiterates Underperform Rating on ProKidney Corp. (PROK)
-
-
-
-
-
-
-
JPMorgan Starts ProKidney Corp. (PROK) at Neutral
-
-
-
-
-
-
-
BofA Securities Reiterates Neutral Rating on ProKidney Corp. (PROK)
-
-
-
433,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

